DarioHealth Corp. (DRIO): Capital Expenditures
$142.0K
Year ended 2025-12-31
$136.0K
Trailing 12 months to 2026-06-30
-31.5%
3-year compound annual growth
+3.8%
5-year compound annual growth
+2.6%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $142.0K | +2.9% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $138.0K | -76.4% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $584.0K | +32.1% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | $442.0K | +69.3% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $261.0K | +121.2% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $118.0K | +20.4% | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $98.0K | +38.0% | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | $71.0K | -63.6% | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | $195.0K | -75.9% | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | $808.0K | +634.5% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $110.0K | -80.5% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $563.0K | -59.8% | 2016-02-08, From 2014-01-01 |
| 2013-12-31 | $1.40M | +161.9% | 2015-03-24, From 2013-01-01 |
| 2012-12-31 | $534.6K | n/a | 2014-03-04, From 2012-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | 2025-12-31 | $142.0K | +2.9% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $42.3K | -98.5% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $192.0K | +140.0% |
| Nephros Inc (NEPH) | 2024-12-31 | $55.0K | -26.7% |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $196.0K | -29.0% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $2.34M | +312.1% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $176.0K | n/a |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $2.55M | +70.8% |
| Allurion Technologies, Inc. (ALUR) | 2024-12-31 | $611.0K | -62.0% |
Compare DRIO, BDMD, SNOA, NEPH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗